Evofosfamide Versus Ifosfamide Patient Selection in Soft Tissue Sarcoma
1 vistas
administrator
07/18/23
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD, PhD; and Shreyaskumar Patel, MD, discuss patient selection and the role of evofosfamide in soft tissue sarcoma.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios